| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.24 | 2e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |